TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Vida Världen Vaccin AB
Closing information (x1000 NOK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
3,984
|
2,601
|
1,604 |
Financial expenses |
11
|
0
![]() |
0 |
Earnings before taxes |
-48
|
43
|
-42 |
EBITDA |
-37
|
43
|
-42 |
Total assets |
1,002
|
851
|
1,086 |
Current assets |
1,002
|
851
|
1,086 |
Current liabilities |
242
|
98
|
58 |
Equity capital |
760
|
753
|
1,029 |
- share capital |
51
|
47
|
49 |
Employees (average) |
2
![]() |
2
![]() |
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
75.8%
|
88.5%
|
94.8% |
Turnover per employee |
1,992
|
1,300
|
802 |
Profit as a percentage of turnover |
-1.2%
|
1.7%
|
-2.6% |
Return on assets (ROA) |
-3.7%
|
5.1%
|
-3.9% |
Current ratio |
414.0%
|
868.4%
|
1872.4% |
Return on equity (ROE) |
-6.3%
|
5.7%
|
-4.1% |
Change turnover |
1,198
|
1,045
|
-623 |
Change turnover % |
43%
|
67%
|
-28% |
Chg. No. of employees |
0
![]() |
0
![]() |
0 |
Chg. No. of employees % |
0%
![]() |
0%
![]() |
0% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.